Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Non Operating Income (2023 - 2025)

Metagenomi (MGX) has disclosed Non Operating Income for 3 consecutive years, with -$11000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 99.72% to -$11000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$91000.0, a 101.71% decrease, with the full-year FY2025 number at -$91000.0, down 101.71% from a year prior.
  • Non Operating Income was -$11000.0 for Q4 2025 at Metagenomi, down from -$2000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $18.3 million in Q4 2023 to a low of -$4.0 million in Q2 2023.
  • A 3-year average of $2.0 million and a median of -$6500.0 in 2025 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: skyrocketed 6547.06% in 2024, then tumbled 5698.04% in 2025.
  • Metagenomi's Non Operating Income stood at $18.3 million in 2023, then crashed by 121.72% to -$4.0 million in 2024, then skyrocketed by 99.72% to -$11000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Non Operating Income are -$11000.0 (Q4 2025), -$2000.0 (Q3 2025), and -$3.0 million (Q2 2025).